Abstract:Objective To evaluate the therapeutic efficacies of preoperative transcatheter arterial chemoembolization (TACE) for hepatoblastoma (HB) in infants.Methods The clinical data were retrospectively collected and analyzed for 15 infants with HB treated between July 2007 and July 2010 at our center.Initial diagnosis was made based on computed tomography (CT) scan and then confirmed by the results of pathological biopsy.After a definite diagnosis,surgical resection was performed (group A,n =4) immediately and followed by TACE (n =11,group B).An intraarterial catheter was inserted selectively into main feeding artery of tumor by Seldinger's method.During angiography,60 mg/m2 cisplatin (CDDP) and 30 mg/m2 pirarubicin (THP) dispersed in iodized oil contrast medium were injected into liver tumor through hepatic artery followed by polyvinyl alcohol (PVA) pieces soaked in contrast medium until main feeding artery became completely embolized.At week 4 postTACE,tumor response and surgical resectability were evaluated by CT scan and alpha fetal protein (AFP).Surgical resection was performed when tumor bulk appeared sufficiently reduced to allow safe resection.Those with pulmonary metastases underwent systemic chemotherapy until the disappearance of metastatic lesions was confirmed with a follow-up CT.TACE was repeated until safe surgical resection.Results TACE was performed successfully in 11 patients.The mean tumor shrinkage rate was 69.83％ (25.22％-91.24％) (t =3.911,P =0.004).AFP level showed a mean decrease of 93.78％ (48.69％-99.79％)(t =4.538,P =0.001).Clinical symptoms of drug-related toxicity were not observed during the course of treatment.Pathological examination of specimens showed a mean level of massive necrosis at 77.67％ (57.91 ％-93.09％).The operative duration was (362.5 ± 44.25)min in group A versus (281.18 ± 46.72) min in group B; The intraoperative blood loss was (50.50 ± 16.42) g/kg in group A versus (29.40 ± 14.11) g/kg in group B; The weight of resected liver was (40.25 ± 8.99) g/kg in group A versus (24.20 ± 5.49) g/kg in group B.Comparison of characteristics of groups A and B revealed that TACE significantly reduced operative duration (t =3.033,P =0.024),rate of intraoperative hemorrhage (t =2.422,P =0.032) and weight of resected liver tissue (t =4.144,P =0.001).Two patients died postoperatively from pulmonary metastasis or tumor recurrence in Group A.Solitary pulmonary metastasis was found in one infant during TACE and another with poorly differentiated hepatoblastoma died postoperatively of tumor progression at month 5 in group B.Eleven of them survived without evidence of disease for 2 years after operation.Conclusions TACE is effective in shrinking tumor volume,decreasing AFP and reducing hemorrhage during operation.And it is safe,useful and efficacious for unresectable infantile hepatoblastoma without serious toxicities or complications.

COMBINED TREATMENT OF HEPATOBLASTOMA WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION AND SURGERY

Three-dimensional Conformal Radiotherapy in Combination with Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma.

Preoperative Transcatheter Selective Arterial Chemoembolization in Treatment of Unresectable Hepatoblastoma in Infants and Children

Application O Preoperative Transcatheter Arterial Chemoembolization in Treatment of Hepatoblastoma

[Clinical Effect of Terminal Branches Portal Vein Embolization Combined with Transcatheter Arterial Chemoembolization on Liver Neoplasms].

Transcatheter arterial chemoembolization in treatment of hepatoblastoma in children:A report of 15 cases

Efficacies of preoperative transcatheter arterial chemoembolization in the treatment of hepatoblastoma in infants

Preoperative interventional therapy for children with unresectable hepatoblastoma

Preoperative Interventional Therapy for Childhood Undifferentiated Embryonal Liver Sarcoma: Two Retrospective Cases from a Single Center

Efficacy and safety of HIFU in combination with TACE in unresectable pediatric HB: A randomized, controlled, single-center clinical trial

Comparison Between Chemoembolization Combined with Radiotherapy and Chemoembolization Alone for Large Hepatocellular Carcinoma

Advance in the Treatment of Children with Hepatoblastoma

Transarterial Chemoembolization Combined with Cryoablation for Unresectable Large Hepatocellular Carcinoma:A Controlled Study

Two-stage Laparoscopic Resection of Giant Hepatoblastoma in Infants Combined with Liver Partial Partition and Artery Ligation

Combined Hepatectomy and Radiofrequency Ablation Versus TACE in Improving Survival of Patients with Unresectable BCLC Stage B HCC.

Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection

TACE Combined with HIFU Versus Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study

Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma.

Treatment of Hepatocellular Carcinoma with Combined Transarterial Chemoembolization and Systemic Therapy

MWA Combined with TACE As a Combined Therapy for Unresectable Large-Sized Hepotocellular Carcinoma

Further treatment of hepatocellular carcinoma after arterial chemoembolization